Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 12,749 clinical trials worldwide
Search
Showing 51-100 of 12,749 trials
Active filters:
Phase: Phase 2
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (12,749)
NCT07060417
Vascular Effects of SGLT2i in Non-diabetic CKD
PHASE2
Not yet recruiting
52 participants
Started: Apr 1, 2026 · Completed: Sep 30, 2029
1 condition
1 sponsor
1 location
NCT06318403
Estradiol Supplementation and Rotator Cuff Repair
PHASE2
Not yet recruiting
58 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2028
5 conditions
1 sponsor
0 locations
NCT06286046
A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
PHASE2
Not yet recruiting
40 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2028
2 conditions
1 sponsor
0 locations
NCT06855043
Little Lungs Study
PHASE2
Not yet recruiting
30 participants
Started: Mar 31, 2026 · Completed: Jan 31, 2028
2 conditions
2 sponsors
2 locations
NCT05029336
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
PHASE2
Recruiting
20 participants
Started: Mar 31, 2026 · Completed: May 31, 2031
2 conditions
1 sponsor
1 location
NCT07178301
Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
PHASE2
Not yet recruiting
100 participants
Started: Mar 20, 2026 · Completed: Mar 20, 2031
2 conditions
2 sponsors
1 location
NCT06137638
ENA-001 for Post Operative Respiratory Depression (PORD)
PHASE2
Not yet recruiting
200 participants
Started: Mar 15, 2026 · Completed: Dec 15, 2026
1 condition
1 sponsor
0 locations
NCT07216950
Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)
PHASE2
Not yet recruiting
260 participants
Started: Mar 11, 2026 · Completed: May 11, 2029
5 conditions
2 sponsors
1 location
NCT07214987
PDT For Induction Therapy For Head And Neck Cancer
PHASE2
Not yet recruiting
26 participants
Started: Mar 9, 2026 · Completed: Sep 1, 2029
3 conditions
2 sponsors
2 locations
NCT07206290
Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
PHASE2
Not yet recruiting
120 participants
Started: Mar 2, 2026 · Completed: Nov 30, 2027
1 condition
1 sponsor
0 locations
NCT07215858
BPL-1357 Against H1N1 Influenza Virus Challenge
PHASE2
Not yet recruiting
126 participants
Started: Mar 2, 2026 · Completed: Mar 1, 2028
2 conditions
1 sponsor
2 locations
NCT07169695
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
PHASE2
Not yet recruiting
120 participants
Started: Mar 2, 2026 · Completed: Jan 21, 2027
1 condition
1 sponsor
0 locations
NCT07111117
Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.
PHASE2
Not yet recruiting
30 participants
Started: Mar 1, 2026 · Completed: Sep 30, 2028
1 condition
1 sponsor
3 locations
NCT06704100
Oral Fosamprenavir + Sodium Alginate for GERD
PHASE2
Not yet recruiting
60 participants
Started: Mar 1, 2026 · Completed: Jun 1, 2028
2 conditions
1 sponsor
1 location
NCT07218302
Eating Disorder Chatbot Optimization
PHASE2
Not yet recruiting
800 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2029
1 condition
3 sponsors
1 location
NCT07206849
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
PHASE2
Not yet recruiting
79 participants
Started: Mar 1, 2026 · Completed: Mar 1, 2037
7 conditions
1 sponsor
0 locations
NCT06809153
Putting Children First - Parent Training for Parents in High Conflict
PHASE2
Not yet recruiting
500 participants
Started: Mar 1, 2026 · Completed: Jan 1, 2027
4 conditions
1 sponsor
0 locations
NCT07209371
Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance
PHASE2
Not yet recruiting
50 participants
Started: Mar 1, 2026 · Completed: May 1, 2028
1 condition
2 sponsors
1 location
NCT07158489
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
PHASE2
Not yet recruiting
47 participants
Started: Mar 1, 2026 · Completed: Mar 31, 2029
2 conditions
1 sponsor
7 locations
NCT03567824
MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
PHASE2
Not yet recruiting
200 participants
Started: Mar 1, 2026 · Completed: Apr 30, 2028
1 condition
1 sponsor
0 locations
NCT07214103
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
PHASE2
Not yet recruiting
120 participants
Started: Mar 1, 2026 · Completed: Dec 31, 2032
2 conditions
1 sponsor
1 location
NCT07139405
TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
PHASE2
Not yet recruiting
90 participants
Started: Feb 28, 2026 · Completed: Jun 30, 2028
1 condition
1 sponsor
0 locations
NCT07162480
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
PHASE2
Not yet recruiting
28 participants
Started: Feb 28, 2026 · Completed: Dec 31, 2031
1 condition
2 sponsors
1 location
NCT07219459
Visugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
PHASE2
Not yet recruiting
104 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2031
3 conditions
1 sponsor
1 location
NCT07153796
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
PHASE2
Not yet recruiting
60 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2033
1 condition
2 sponsors
1 location
NCT07123090
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
PHASE2
Not yet recruiting
25 participants
Started: Feb 28, 2026 · Completed: Feb 1, 2028
6 conditions
2 sponsors
2 locations
NCT07123649
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
PHASE2
Not yet recruiting
364 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2029
1 condition
2 sponsors
1 location
NCT06917001
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)
PHASE2
Not yet recruiting
120 participants
Started: Feb 28, 2026 · Completed: Dec 31, 2027
1 condition
2 sponsors
2 locations
NCT07137481
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
PHASE2
Not yet recruiting
70 participants
Started: Feb 28, 2026 · Completed: Jul 31, 2032
1 condition
1 sponsor
1 location
NCT07164469
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
PHASE2
Not yet recruiting
100 participants
Started: Feb 28, 2026 · Completed: Sep 30, 2033
2 conditions
2 sponsors
1 location
NCT07187778
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
PHASE2
Not yet recruiting
10 participants
Started: Feb 28, 2026 · Completed: Jul 19, 2029
1 condition
2 sponsors
1 location
NCT07192237
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
PHASE2
Not yet recruiting
40 participants
Started: Feb 27, 2026 · Completed: Oct 12, 2032
3 conditions
2 sponsors
1 location
NCT07178912
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
PHASE2
Not yet recruiting
60 participants
Started: Feb 27, 2026 · Completed: Sep 30, 2031
5 conditions
3 sponsors
1 location
NCT07153497
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
PHASE2
Not yet recruiting
132 participants
Started: Feb 26, 2026 · Completed: Apr 26, 2030
2 conditions
1 sponsor
0 locations
NCT07169617
Testing the SurVaxM Vaccine for Lung Cancer Prevention
PHASE2
Not yet recruiting
80 participants
Started: Feb 25, 2026 · Completed: Sep 30, 2027
1 condition
1 sponsor
4 locations
NCT06804655
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
PHASE2
Not yet recruiting
40 participants
Started: Feb 12, 2026 · Completed: Sep 15, 2028
8 conditions
4 sponsors
3 locations
NCT07133425
A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
PHASE2
Not yet recruiting
29 participants
Started: Feb 5, 2026 · Completed: Feb 1, 2030
2 conditions
2 sponsors
1 location
NCT06696755
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
PHASE2
Not yet recruiting
195 participants
Started: Feb 5, 2026 · Completed: Nov 30, 2027
2 conditions
1 sponsor
0 locations
NCT06820138
Focused Ultrasound for PTSD in Veterans
PHASE2
Not yet recruiting
60 participants
Started: Feb 2, 2026 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT05402332
Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)
PHASE2
Not yet recruiting
8 participants
Started: Feb 2, 2026 · Completed: Mar 2, 2028
1 condition
2 sponsors
1 location
NCT05776381
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
PHASE2
Not yet recruiting
110 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2030
6 conditions
1 sponsor
0 locations
NCT07152626
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
PHASE2
Not yet recruiting
56 participants
Started: Feb 1, 2026 · Completed: Apr 1, 2029
1 condition
1 sponsor
1 location
NCT07148947
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
PHASE2
Not yet recruiting
27 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT07207785
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
PHASE2
Not yet recruiting
56 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2030
1 condition
1 sponsor
20 locations
NCT04003285
Allopregnanolone in Chronic Complex Traumatic Brain Injury
PHASE2
Not yet recruiting
132 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2027
1 condition
1 sponsor
1 location
NCT06727786
Serious Game to Teach Opioid Overdose Response
PHASE2
Not yet recruiting
850 participants
Started: Feb 1, 2026 · Completed: Dec 1, 2027
1 condition
1 sponsor
0 locations
NCT06408246
ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial
PHASE2
Not yet recruiting
160 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2029
1 condition
1 sponsor
2 locations
NCT07143968
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
PHASE2
Not yet recruiting
120 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2028
2 conditions
1 sponsor
0 locations
NCT03643367
Sevoflurane Sedation in Patients With Septic Shock
PHASE2
Not yet recruiting
153 participants
Started: Jan 31, 2026 · Completed: Nov 30, 2027
1 condition
4 sponsors
4 locations
NCT07191977
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma
PHASE2
Not yet recruiting
41 participants
Started: Jan 31, 2026 · Completed: Dec 31, 2029
1 condition
1 sponsor
0 locations
Previous
1
2
2
3
4
5
More pages
255
Next